Use of glucagon-like peptide-1 (GLP-1) agonists in modulating preexisting dermatologic disease: a systematic review
Concurrent use with other sympathomimetics (OTC cold medications) may produce hypertension
Several pro-angiogenic factors have been identified and leveraged in developing diverse anti-tumor therapies, including receptor tyrosine kinase (RTK) signaling proteins, hypoxia-inducible factor (HIF), vascular endothelial growth factor (VEGF), thrombospondin-1 (TSP-1), plasminogen-plasmin system, and reactive oxygen species (ROS)
However, safety and efficacy depend heavily on choosing a qualified practitioner and adhering to recommended guidelines
A Witschi , S Reddy, B Stofer, B H Lauterburg The systemic availability of oral glutathione
Physical Symptoms That Can Warn You About Mood Problems Unexplained fatigue that is deeper than simple tiredness may signal emerging depression or poor nutrition